Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesShimon Slavin, Reuven Or, Simcha Samuel et al.|Blood|1998Cited by 1.9k
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesShimon Slavin, Reuven Or, Arnon Nagler et al.|Blood|1998Cited by 1.8k
ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)Herman Waldmann, S Slavin, G Hale et al.|The Lancet|1984Cited by 424
The beneficial role of inhibitory <i>KIR</i> genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor‐alloreactive T cells causing GVHDAmal Bishara, S Slavin, Dianne De Santis et al.|Tissue Antigens|2004Cited by 145
Common variable immunodeficiency: A family study and therapeutic trial with cimetidineRaphael Segal, S Peller, Rita Michalevitch et al.|Journal of Allergy and Clinical Immunology|1989Cited by 17